These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19067988)

  • 1. Demystifying good high-density lipoprotein from dysfunctional high-density lipoprotein.
    Drown DJ
    Prog Cardiovasc Nurs; 2008; 23(4):198-9. PubMed ID: 19067988
    [No Abstract]   [Full Text] [Related]  

  • 2. Frontiers in research series: Physiological and pathological functions of high-density lipoprotein. Introduction.
    Sviridov D
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):700-2. PubMed ID: 20374253
    [No Abstract]   [Full Text] [Related]  

  • 3. High-density lipoprotein cholesterol: current perspective for clinicians.
    Whayne TF
    Angiology; 2009; 60(5):644-9. PubMed ID: 19240106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heart of the matter: reducing CVD risk.
    Hayman LL; Kamau MW; Stuart-Shor EM
    Nurse Pract; 2009 May; 34(5):30-5. PubMed ID: 19390396
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
    Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
    Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
    Alagona P
    Am J Manag Care; 2009 Mar; 15(3 Suppl):S65-73. PubMed ID: 19355805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges.
    Rosenson RS; Brewer HB; Ansell B; Barter P; Chapman MJ; Heinecke JW; Kontush A; Tall AR; Webb NR
    Circulation; 2013 Sep; 128(11):1256-67. PubMed ID: 24019446
    [No Abstract]   [Full Text] [Related]  

  • 8. Stair use for cardiovascular disease prevention.
    Meyer P; Kayser B; Mach F
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S17-8. PubMed ID: 19675430
    [No Abstract]   [Full Text] [Related]  

  • 9. Systematic risk assessment key to CVD prevention.
    Savill P
    Practitioner; 2008 Jun; 252(1707):19, 21-2, 25-6. PubMed ID: 18669367
    [No Abstract]   [Full Text] [Related]  

  • 10. The cardiovascular prevention and lifestyle quiz for cardiologists.
    De Sutter J; Conraads VM
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S8-10. PubMed ID: 19675443
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
    Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of dyslipidaemia - evidence and practical recommendations.
    Nestel PJ; O'Brien R; Nelson M
    Aust Fam Physician; 2008 Jul; 37(7):521-7. PubMed ID: 18592069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to rethink high-density lipoprotein?
    Wild S; Byrne CD
    Heart; 2008 Jun; 94(6):692-4. PubMed ID: 18480346
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertriglyceridemia and cardiovascular disease management.
    Codario RA
    J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):7-10, 13-4. PubMed ID: 18510282
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factor management: a practice guide.
    Perk J
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S24-8. PubMed ID: 19675433
    [No Abstract]   [Full Text] [Related]  

  • 16. [Education program for patients with cardiovascular risks].
    Abadie A; Bertoia M; Lorente C; Spinazze-Fournier L
    Soins; 2007; (712 Suppl):S15-7. PubMed ID: 17375596
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary prevention of cardiovascular diseases by lowering lipids].
    Klose G
    Internist (Berl); 1997 Jun; 38(6):615-6. PubMed ID: 9265009
    [No Abstract]   [Full Text] [Related]  

  • 18. Hope for the future: early recognition of increased cardiovascular risk in children and how to deal with it.
    Masi S; Charakida M; Wang G; O'Neill F; Taddei S; Deanfield J
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S61-4. PubMed ID: 19675441
    [No Abstract]   [Full Text] [Related]  

  • 19. The challenge for preventive cardiology.
    Kotseva K; Wood D
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S19-23. PubMed ID: 19675431
    [No Abstract]   [Full Text] [Related]  

  • 20. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
    Sacks FM
    Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.